#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Renal disorder Chronic graft versus host disease in liver Cholangiocarcinoma Congenital generalised lipodystrophy Cerebellar ataxia Anti-HLA antibody test positive Idiopathic inflammatory myopathy Amyotrophic lateral sclerosis gene carrier Glomerulonephritis minimal lesion Chronic lymphocytic leukaemia refractory Hyperchylomicronaemia Fragile X syndrome Haemophilia Congenital growth hormone deficiency Neuroendocrine cell hyperplasia of infancy More trials…
Learn about Rare Diseases

IgA nephropathy – Life with Disease Brain stem glioma – Basic Information Skin angiosarcoma Hairy cell leukaemia recurrent – Basic Information MELAS syndrome – Trials in Disease Alveolar rhabdomyosarcoma – Basic Information Splenic marginal zone lymphoma – Diagnostics Rhabdoid tumour Osteosarcoma – Diagnostics Rett syndrome – Diagnostics More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Nnc0194-0499 Ds-3939A Brepocitinib Tosilate Beclometasone Dipropionate Odronextamab Paracetamol Ph. Eur. Xtmab-16 Toldc Fenfluramine Hydrochloride Gs-4182 Air, Medicinal Elenestinib Phosphate Bintrafusp Alfa Sargramostim Leuprorelin Fluorouracil Sodium Aluminium Bgb-A445 Labetalol Hydrochloride RNMB2 More therapies…

Learn about Your Condition

Ectopic pregnancy Cardiac ventricular thrombosis Dystonic tremor SAPHO syndrome Metastases to lymph nodes CADASIL Complex regional pain syndrome Niemann-Pick disease Diffuse large B-cell lymphoma Trigeminal neuralgia Rhabdoid tumour of the kidney Vertigo Acute respiratory failure Rosai-Dorfman syndrome Primary hypercholesterolaemia More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Splenic marginal zone lymphoma

Epcoritamab for Adults with Relapsed or Refractory Marginal Zone Lymphoma: A Phase II Open‑Label Study

Not yet recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Epcoritamab
Study of Obinutuzumab as First-Line Treatment for Adult Patients with Marginal Zone Lymphoma Who Are Not Eligible for Local Therapy

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Obinutuzumab
Study on Copanlisib and Rituximab for Patients with Marginal Zone Lymphoma Needing Treatment After Local Therapy Failure or Relapse

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Copanlisib Dihydrochloride
- Rituximab
Study Comparing Rituximab and Zanubrutinib with Rituximab Alone for Untreated Patients with Splenic Marginal Zone Lymphoma

Not recruiting

3 1 1 1
Investigated Drugs:
- Zanubrutinib
- Rituximab
+1

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Splenic marginal zone lymphoma

Epcoritamab for Adults with Relapsed or Refractory Marginal Zone Lymphoma: A Phase II Open‑Label Study

Study of Obinutuzumab as First-Line Treatment for Adult Patients with Marginal Zone Lymphoma Who Are Not Eligible for Local Therapy

Study on Copanlisib and Rituximab for Patients with Marginal Zone Lymphoma Needing Treatment After Local Therapy Failure or Relapse

Study Comparing Rituximab and Zanubrutinib with Rituximab Alone for Untreated Patients with Splenic Marginal Zone Lymphoma

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies